B18 peptide
B18 peptide is a cationic amphipathic α-helical peptidomimetic that binds to the BST-2 extracellular domain and forms a stable complex through intermolecular hydrogen bonds near the N-terminus. B18 peptide competitively inhibits the binding of BST-2 to the extracellular matrix via its extracellular domain, reducing migrasome formation. B18 peptide induces membrane lysis through the formation of pores/water channels and annular pores, impairing membrane integrity. B18 peptide exhibits anticancer activity against breast cancer. B18 peptide can be used for research on breast cancer.
For research use only. We do not sell to patients.
- CAS No.: 3027663-77-7
- Formula: C78H121N23O28S2
- Molecular Weight:1893.06
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MCF7 | IC50 |
59.8 μM
|
Cytotoxicity against human MCF7 breast cancer cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay.
Cytotoxicity against human MCF7 breast cancer cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay.
|
32155736 |
| SK-BR-3 | IC50 |
11.2 μM
|
Cytotoxicity against human SKBR3 breast cancer cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay.
Cytotoxicity against human SKBR3 breast cancer cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay.
|
32155736 |
In Vitro
B18 peptide significantly reduces migrasome formation by competitively inhibiting BST2-mediated extracellular matrix adhesion[2].
B18 peptide (0.5-132.0 μM; 24 h) exhibited selective cytotoxic effects, reducing the viability of MCF7 and SKBR3 breast cancer cells, while showing no cytotoxic effects on MDA-MB-231, MDA-MB-468, T47D, and ZR-75-1 cells, and enhanced the viability of PBMCs at high concentrations[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MCF7, SKBR3, MDA-MB-231, MDA-MB-468, T47D, ZR-75-1, and human PBMCs
-
Concentration:0, 0.5, 1.0, 2.1, 4.1, 8.3, 16.5, 33.0, 66.0, 132.0 μM
-
Incubation Time:24 h
-
Result:Reduced cell viability for MCF7 and SKBR3 cell lines with IC50 values of 59.8 μM and 11.2 μM, respectively.
No significant loss of viability was observed for MDA-MB-231, MDA-MB-468, T47D, and ZR-75-1 cell lines, even at the highest concentration tested.
No cytotoxic effect was observed for quiescent human PBMCs; however, at concentrations of 66.0 and 132.0 μM, B18 enhanced cell viability.
Subtle increases in viability were also observed in T47D cells.
Chemical Information
-
CAS No. 3027663-77-7
-
Molecular Weight 1893.06
-
Formula C78H121N23O28S2
-
SMILES
O=C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](C(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](C)C(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H]([C@H](O)C)C(N[C@@H](CS)C(N[C@@H](CC(N)=O)C(N[C@@H](CC2=CNC=N2)C(N[C@@H]([C@H](O)C)C(N[C@@H](C(C)C)C(N[C@@H](CCSC)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CN
-
Sequence
Gly-Phe-Gln-Asp-Val-Glu-Ala-Gln-Ala-Ala-Thr-Cys-Asn-His-Thr-Val-Met-Ala
-
Sequence Shortening
GFQDVEAQAATCNHTVMA
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Fibrosis/Collagen Morphometry
Fibrosis and collagen morphometry is based on the quantitative visualization of fibrillar collagen deposition in tissue sections using histochemical stains such as Sirius Red (Picrosirius Red) or Masson's trichrome, followed by image-based or polarization-enhanced analysis to estimate collagen proportional area as a surrogate of extracellular matrix accumulation during fibrotic remodeling. Sirius Red combined with polarized light microscopy enhances detection of collagen fibers due to birefringence properties, enabling more specific visualization of collagen type I and III fibrils compared to conventional bright-field histology, while whole-section or region-restricted digital morphometry reduces field-selection bias in fibrosis assessment. Alternative quantitative approaches include second harmonic generation (SHG) and two-photon excited fluorescence microscopy, which enable label-free detection of fibrillar collagen and have been validated against histological staining and biochemica
-
Collagen: Sirius Red Staining
Sirius Red or picrosirius red staining is a histochemical method for visualizing collagen-rich extracellular matrix in tissue sections, and collagen fibers are detected as red-stained structures under bright-field microscopy with enhanced birefringence under polarized light. Picrosirius red is useful for assessing total collagen organization, distribution, and fibrosis burden, but polarized color should not be interpreted as a definitive collagen type I versus type III readout because color is affected by fiber orientation, thickness, and packing.
-
ECM-Embedded Organoid (Matrigel/Dome) Culture
ECM-embedded organoid dome culture embeds epithelial stem cells, crypts, organoid fragments, or tumor-derived epithelial cells in a basement-membrane-like hydrogel such as Matrigel, allowing 3D growth, self-organization, lumen formation, budding or cystic morphogenesis, and lineage maintenance under defined niche-factor-containing medium. The primary readouts are organoid establishment efficiency, growth, morphology, passaging capacity, lineage-marker expression, and, when fluorescently labeled lines are used, microscopy- or flow-cytometry-based quantification of population behavior in 3D culture.
-
Matrigel/ECM Transwell Invasion Assay
The Matrigel/ECM Transwell invasion assay measures the ability of cells to move toward a chemoattractant while crossing an extracellular-matrix barrier placed on a porous membrane; therefore, the readout reflects both chemotactic motility and matrix invasion rather than migration alone. Matrigel is a basement-membrane-rich matrix derived from Engelbreth-Holm-Swarm mouse sarcoma and has been used as a reconstituted basement membrane barrier in chemoinvasion assays. The assay readout is generated by quantifying cells that reach the underside of the insert membrane or lower compartment after incubation, commonly by staining and counting invaded cells or by fluorescence-based quantification.
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Matrigel Transwell/Boyden Chamber Invasion Assay
Matrigel Transwell/Boyden chamber invasion assay measures the ability of cells to degrade or traverse an extracellular matrix-coated porous membrane and move from an upper chamber toward a chemoattractant in a lower chamber. Invasion is distinguished from migration by coating the membrane with Matrigel or basement membrane matrix; uncoated inserts measure migration, while coated inserts require cells to cross an ECM barrier before reaching the underside of the membrane.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)